Once-yearly Histrelin Implant Provides Sustained Improvement in Prostate Cancer Patients
BARCELONA—Investigators have documented the long-term efficacy and tolerability of a once-yearly histrelin subdermal implant in men with advanced prostate cancer.
SAN DIEGO—Creative strategies used by local chapters of the Oncology Nursing Society (ONS) to recruit and retain members and reach out to their local communities were described in poster presentations at the 2010 Congress. Using these strategies, the chapters not only increased membership but also strengthened ties with their communities.
San Diego ONS chapter meets goal of 210 by 2010
For patients with relapsed or refractory multiple myeloma (MM), bortezomib-based therapy is effective after lenalidomide plus dexamethasone (LD), according to a Canadian study that evaluated sequencing of novel agents presented at the 51st Annual Meeting and Exposition of the American Society of Hematology.
Nurses from around the world met in Atlanta, Georgia, in March to attend the 16th International Conference on Cancer Nursing, cosponsored by the International Society of Nurses in Cancer Care (ISNCC) and the National Headquarters and South Atlantic Division of the American Cancer Society. The theme of the conference was Enhancing Knowledge, Promoting Quality.
Results 431 - 434 of 434